2m 2m 2m 2m 2m 2m 2m
Vericel (VCEL)
NASDAQ
$42.65-$0.03 (-0.07%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.2BMarket Cap
- 15.26%1-Year Change
- BiotechnologyIndustry
Vericel (VCEL)
$42.65-$0.03 (-0.07%)
VCEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $42.68 | ||
Change | +$0.57 (+1.35%) | ||
Open | $42.36 | ||
High | $42.85 | ||
Low | $41.76 | ||
Previous Close | $42.11 | ||
Volume | 647,128 | ||
30-Day Average Volume | 483,209 | ||
1-Week Change | -3.44% | ||
1-Month Change | -7.50% | ||
1-Year Change | 15.26% | ||
3-Year Change | 31.81% | ||
5-Year Change | -14.98% | ||
Fundamentals | |||
Shares Outstanding | 51.2M | ||
Total Assets | $502.9M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $77.5M | ||
Net Income | $2.2M | ||
Free Cash Flow | $14.3M | ||
EBIT | $2.2M | ||
EBITDA | $5.8M | ||
Net Working Capital | $212.2M | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 354 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 6 | ||
P/E | 1,067 | ||
PEG | 8 | ||
Price/Free Cash Flow | 153 | ||
Price/Operating Cash Flow | 135 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/16/2013 | ||
Earnings & Revenue